Delivery Order SPE2DR25D1053-SPE2DR26FT288
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $10,543.64 firm fixed-price delivery order for M-M-R II vaccine vials, with a completion date of September 2, 2025. This competitively awarded contract, with no set-aside designation, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999 and extends through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $5,014.49 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with a completion date of September 25, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract will be performed at AmerisourceBergen's Corporate Office...
- The Defense Logistics Agency awarded a $1,479.80 firm fixed price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 25, 2025. This non-set-aside contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The vaccine delivery will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency has awarded a delivery order valued at $1,119.10 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 18, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $7,720.60 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of August 19, 2025. This competitive award utilizes firm fixed pricing and carries no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued as a child contract under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $11,852.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 12, 2025. This non-competitive, competitively awarded delivery order will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract action under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion...
- The Defense Logistics Agency awarded a $2,769.45 delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 29, 2025. This competitive award employs firm fixed-price pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a...
- The Defense Logistics Agency awarded a delivery order valued at $8,096.44 to AmerisourceBergen Drug Corp on July 29, 2025, for M-M-R II vaccine vials. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order valued at $4,772.92 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials valued at $4,809.99, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is listed as Conshohocken,...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT288Delivery Order
The Defense Logistics Agency awarded a $10,800.65 firm fixed-price delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of October 27, 2025. This non-set-aside contract represents a child award under AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor agreement designated SPE2DX that runs through December 2026. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains a significant federal procurement presence primarily supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive contract portfolio demonstrates consistent capability to deliver pharmaceuticals and medical supplies competitively across therapeutic domains, including vaccines, specialty medications, and medical devices. This delivery order for measles-mumps-rubella vaccine vials reflects the company's core role as a critical supplier of immunization products and other essential medical commodities to support Department of Defense healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 10/24/25 |